Kyler Lei

Kyler Lei

Director of Finance/CFO at NOVABRIDGE BIOSCIENCES
29 year
Health Technology
Consumer Services
Finance

Profile

Kyler Lei is currently Chief Financial Officer at NovaBridge Biosciences since 2025.
Formerly, Mr. Lei was Deputy General Manager & Head-Capital Markets at Sino Biopharmaceutical Ltd. from 2022 to 2025, Research Analyst at Daiwa Capital Markets (Hong Kong) Ltd. from 2020 to 2021, and Analyst at Macquarie Capital Ltd. from 2018 to 2020.
Education includes an undergraduate degree from The University of Hong Kong conferred in 2019 and a graduate degree from The Hong Kong University of Science & Technology conferred in 2022.

Kyler Lei active positions

CompaniesPositionStart
NOVABRIDGE BIOSCIENCES Director of Finance/CFO 15/10/2025

Former positions of Kyler Lei

CompaniesPositionEnd
SINO BIOPHARMACEUTICAL LIMITED Corporate Officer/Principal 30/09/2025
Analyst-Equity 31/05/2021
Analyst-Equity 31/05/2020
See the detail of Kyler Lei's experience

Training of Kyler Lei

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

39

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Finance

Consumer Services

Finance

Health Technology